Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 5
2008 5
2009 7
2010 7
2011 8
2012 9
2013 12
2014 9
2015 8
2016 12
2017 15
2018 18
2019 14
2020 14
2021 18
2022 10
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth.
Morgenstern A, Apostolidis C, Kratochwil C, Sathekge M, Krolicki L, Bruchertseifer F. Morgenstern A, et al. Among authors: bruchertseifer f. Curr Radiopharm. 2018;11(3):200-208. doi: 10.2174/1874471011666180502104524. Curr Radiopharm. 2018. PMID: 29732998 Free PMC article. Review.
Targeted alpha therapy for glioblastoma.
Kunikowska J, Morgenstern A, Pełka K, Bruchertseifer F, Królicki L. Kunikowska J, et al. Among authors: bruchertseifer f. Front Med (Lausanne). 2022 Dec 16;9:1085245. doi: 10.3389/fmed.2022.1085245. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36590948 Free PMC article. Review.
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.
Feuerecker B, Tauber R, Knorr K, Heck M, Beheshti A, Seidl C, Bruchertseifer F, Pickhard A, Gafita A, Kratochwil C, Retz M, Gschwend JE, Weber WA, D'Alessandria C, Morgenstern A, Eiber M. Feuerecker B, et al. Among authors: bruchertseifer f. Eur Urol. 2021 Mar;79(3):343-350. doi: 10.1016/j.eururo.2020.11.013. Epub 2020 Dec 5. Eur Urol. 2021. PMID: 33293081
Supply and Clinical Application of Actinium-225 and Bismuth-213.
Morgenstern A, Apostolidis C, Bruchertseifer F. Morgenstern A, et al. Among authors: bruchertseifer f. Semin Nucl Med. 2020 Mar;50(2):119-123. doi: 10.1053/j.semnuclmed.2020.02.003. Epub 2020 Feb 21. Semin Nucl Med. 2020. PMID: 32172796 Free PMC article. Review.
[Alpha-Radioimmunotherapy: principle and relevance in anti-tumor immunity].
Ménager J, Gorin JB, Fichou N, Gouard S, Morgenstern A, Bruchertseifer F, Davodeau F, Kraeber-Bodéré F, Chérel M, Gaschet J, Guilloux Y. Ménager J, et al. Among authors: bruchertseifer f. Med Sci (Paris). 2016 Apr;32(4):362-9. doi: 10.1051/medsci/20163204014. Epub 2016 May 2. Med Sci (Paris). 2016. PMID: 27137693 Free article. Review. French.
225Ac- and 213Bi-Substance P Analogues for Glioma Therapy.
Królicki L, Kunikowska J, Bruchertseifer F, Koziara H, Królicki B, Jakuciński M, Pawlak D, Rola R, Morgenstern A, Rosiak E, Merlo A. Królicki L, et al. Among authors: bruchertseifer f. Semin Nucl Med. 2020 Mar;50(2):141-151. doi: 10.1053/j.semnuclmed.2019.11.004. Semin Nucl Med. 2020. PMID: 32172799 Free article. Review.
Targeted alpha therapy with 213Bi.
Morgenstern A, Bruchertseifer F, Apostolidis C. Morgenstern A, et al. Among authors: bruchertseifer f. Curr Radiopharm. 2011 Oct;4(4):295-305. doi: 10.2174/1874471011104040295. Curr Radiopharm. 2011. PMID: 22202152 Review.
156 results